35,787 results on '"Nephropathy"'
Search Results
2. A Study of Mitapivat in Participants With Sickle Cell Disease and Nephropathy
- Published
- 2024
3. Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose-coTransporter Inhibitors Avoiding Kidney hypOxia (PLUTO)
- Author
-
Juvenile Diabetes Research Foundation, King's College London, and Glostrup University Hospital, Copenhagen
- Published
- 2024
4. VIRTUUS Children's Study (VIRTUUS)
- Author
-
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Published
- 2024
5. Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes (IMPROVE-T2D)
- Published
- 2024
6. Prediction of BKvirus Nephropathy Risk by the NEPHROVIR Method in Kidney Transplant Patients With BKvirus Viremia (BK-VIR)
- Author
-
SATT Paris Saclay
- Published
- 2024
7. The Role of Renal Progenitors and Polyploid Tubular Cell Response in Glomerular and Tubular Diseases
- Author
-
Paola Romagnani, Professor, MD, PhD
- Published
- 2024
8. APOL1 Genetic Testing in African Americans
- Author
-
Mid-America Transplant and Krista Lentine MD, PhD, Principal Investigator
- Published
- 2024
9. Nail-patella syndrome with nephropathy in a de novo LMX1B mutation: triangular lunula of the thumb and lack of finger creases as clues.
- Author
-
Banno, Yoshinori, Ikemiyagi, Masako, Hamada, Riku, Nozu, Kandai, Matsuoka, Kentaro, and Kamimaki, Isamu
- Subjects
- *
FINGER abnormalities , *FINGER physiology , *PROTEINS , *PROTEINURIA , *BIOPSY , *TRANSCRIPTION factors , *THUMB , *NAIL-patella syndrome , *GENETIC mutation , *KIDNEY diseases - Abstract
Nail-patella syndrome (NPS) is an autosomal dominant disease caused mostly by mutations in the LMX1B gene and is characterized by hypoplastic nails, hypoplastic patella, elbow deformities, glaucoma, and nephropathy, sometimes leading to kidney failure. The combination and the severity of symptoms vary greatly from patient to patient. Because a kidney biopsy may show nonspecific findings, patients with nephropathy alone may not be diagnosed without undergoing genetic testing. We examined the case of a 6-year-old girl with persistent high proteinuria who was not diagnosed by kidney biopsy but had a diagnosis of a de novo mutation in the LMX1B gene following genetic testing. Retrospectively, only the thumbs showed triangular lunulae, while the third and fourth fingers lacked skin creases over the distal interphalangeal joints, which is subtle but characteristic of NPS. Notifying pediatric nephrologists of these findings can help avoid unnecessary kidney biopsies and lead to early detection of the disease. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. The relationship between hypomagnesemia and albuminuria in patients with type 2 diabetes mellitus.
- Author
-
Eker, Edibe S. and Ataoğlu, Hayriye E.
- Subjects
- *
TYPE 2 diabetes , *DIABETIC nephropathies , *LOGISTIC regression analysis , *CHRONIC kidney failure , *HYPOMAGNESEMIA - Abstract
Objective: Diabetic nephropathy is a prevalent cause of chronic kidney disease worldwide. Magnesium plays a critical role in insulin resistance, and insulin, in turn, regulates magnesium levels. We aimed to investigate the association between hypomagnesemia and albuminuria in patients with type 2 diabetes mellitus (T2DM). Design, Patients and Measurements: This retrospective single‐centre study encompassed 1178 patients aged 18 and above with T2DM, who attended our outpatient clinic between January 2019 and August 2020. Albuminuria levels were categorised according to Kidney Disease Outcomes Quality Initiative guidelines. In the literature, when examining cut‐off values for hypomagnesemia, it is observed that studies typically use hospital normal level as a reference point. Hypomagnesemia, defined as magnesium levels below 1.6 mg/dL, was compared to normomagnesemia (magnesium between 1.6 and 2.4 mg/dL). The primary objective was to explore the impact of magnesium levels on albuminuria, while the secondary objective was to determine the prevalence of hypomagnesemia. The multivariate logistic regression analyses were performed according to age, gender (male), HbA1c, and presence of hypomagnesemia. Results: The mean age of the participants was 58.7 ± 12.2 years, with 44% being male. Hypomagnesemia was identified in 5.3% of the patients. Advanced age and female gender were more common among patients with hypomagnesemia (p =.001). Magnesium levels exhibited a negative correlation with HbA1c and fasting blood glucose, and a positive correlation with creatinine levels (r = −.117, r = −.131, r =.117, p <.001 for all three variables). Hypomagnesemia was significantly more prevalent in patients with albuminuria (15.9% vs. 4.7%, p <.001). Moreover, participants with the presence of hypomagnesemia were independently associated with a higher risk of albuminuria (odds ratio 3,64 1.76–7.52, p =.001). Conclusion: Albuminuria is more frequently observed in patients with hypomagnesemia. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
11. Role of Synbiotics (Prebiotics and Probiotics) as Dietary Supplements in Type 2 Diabetes Mellitus Induced Health Complications.
- Author
-
Baghel, Kalpana, Khan, Aamir, and Kango, Naveen
- Subjects
- *
MYOCARDIAL infarction , *SYNBIOTICS , *TYPE 2 diabetes , *STROKE , *BLINDNESS , *DIETARY supplements , *DISEASE complications - Abstract
Diabetes is a metabolic disorder whose prevalence has become a worrying condition in recent decades. Chronic diabetes can result in serious health conditions such as impaired kidney function, stroke, blindness, and myocardial infarction. Despite a variety of currently available treatments, cases of diabetes and its complications are on the rise. This review article provides a comprehensive account of the ameliorative effect of prebiotics and probiotics individually or in combination i.e. synbiotics on health complications induced by Type 2 Diabetes Mellitus (T2DM). Recent advances in the field underscore encouraging outcomes suggesting the consumption of synbiotics leads to favorable changes in the gut microbiota. These changes result in the production of bioactive metabolites such as short-chain fatty acids (crucial for lowering blood sugar levels), reducing inflammation, preventing insulin resistance, and encouraging the release of glucagon-like peptide-1 in the host. Notably, novel strategies supplementing synbiotics to support gut microbiota are gaining attraction as pivotal interventions in mitigating T2DM-induced health complications. Thus, by nurturing a symbiotic relationship between prebiotics and probiotics i.e. synbiotics, these interventions hold promise in reshaping the microbial landscape of the gut thereby offering a multifaceted approach to managing T2DM and its associated morbidities. Supporting the potential of synbiotics underscores a paradigm shift toward holistic and targeted interventions in diabetes management, offering prospects for improved outcomes and enhanced quality of life for affected individuals. Nevertheless, more research needs to be done to better understand the single and multispecies pre/pro and synbiotics in the prevention and management of T2DM-induced health complications. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. Renoprotective Effects of Metabolic Surgery Versus GLP1 Receptor Agonists on Progression of Kidney Impairment in Patients with Established Kidney Disease.
- Author
-
Aminian, Ali, Gasoyan, Hamlet, Zajichek, Alexander, Alavi, Mohammad Hesam, Casacchia, Nicholas J., Wilson, Rickesha, Xiaoxi Feng, Corcelles, Ricard, Brethauer, Stacy A., Schauer, Philip R., Kroh, Matthew, Rosenthal, Raul J., Taliercio, Jonathan J., Poggio, Emilio D., Nissen, Steven E., and Rothberg, Michael B.
- Abstract
Objective: To examine the renoprotective effects of metabolic surgery in patients with established chronic kidney disease (CKD). Background: The impact of metabolic surgery compared with glucagon-like peptide-1 receptor agonists (GLP-1RA) in patients with established CKD has not been fully characterized. Methods: Patients with obesity (body mass index =30 kg/m²), type 2 diabetes, and baseline estimated glomerular filtration rate (eGFR) 20-60 mL/min/1.73 m² who underwent metabolic bariatric surgery at a large US health system (2010-2017) were compared with nonsurgical patients who continuously received GLP-1RA. The primary end point was CKD progression, defined as a decline of eGFR by =50% or to <15 mL/min/1.73 m2, initiation of dialysis, or kidney transplant. The secondary end point was the incident kidney failure (eGFR <15 mL/min/1.73 m2, dialysis, or kidney transplant) or all-cause mortality. Results: 425 patients, including 183 patients in the metabolic surgery group and 242 patients in the GLP-1RA group, with a median follow-up of 5.8 years (IQR, 4.4-7.6), were analyzed. The cumulative incidence of the primary end point at 8 years was 21.7% (95% CI: 12.2-30.6) in the surgical group and 45.1% (95% CI: 27.7 to 58.4) in the nonsurgical group, with an adjusted hazard ratio of 0.40 (95% CI: 0.21 to 0.76), P=0.006. The cumulative incidence of the secondary composite end point at 8 years was 24.0% (95% CI: 14.1 to 33.2) in the surgical group and 43.8% (95% CI: 28.1 to 56.1) in the nonsurgical group, with an adjusted HR of 0.56 (95% CI: 0.31 to 0.99), P= 0.048. Conclusions: Among patients with type 2 diabetes, obesity, and established CKD, metabolic surgery, compared with GLP-1RA, was significantly associated with a 60% lower risk of progression of kidney impairment and a 44% lower risk of kidney failure or death. Metabolic surgery should be considered as a therapeutic option for patients with CKD and obesity. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. Immunoglobulin A vasculitis with periorbital edema and severe renal involvement: A case report.
- Author
-
Chiu, Le Wen, Dibas, Basema I., Walker, Patrick D., Smidt, Aimee C., and Konstantinov, Nikifor K.
- Subjects
- *
IMMUNOGLOBULIN A , *VASCULITIS , *KIDNEY injuries , *EDEMA , *GLOMERULONEPHRITIS - Abstract
Immunoglobulin A (IgA) vasculitis, or Henoch‐Schonlein purpura, is the most common systemic vasculitis in children, clinically presenting as palpable purpura in combination with arthritis, gastrointestinal involvement, or kidney injury. Subcutaneous edema is reported in patients with IgA vasculitis, and it commonly affects the lower extremities, especially around joints. Here, we report a case of IgA vasculitis with a rare presentation of edema isolated to the periorbital area in a 7‐year‐old boy, who subsequently developed crescentic glomerulonephritis with nephrotic range proteinuria. Isolated periorbital edema is an uncommon cutaneous feature of IgA vasculitis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. Association of Helicobacter pylori infection with complications of diabetes: a single-center retrospective study.
- Author
-
Li, Zhuoya, Zhang, Jie, Jiang, Yizhou, Ma, Kai, Cui, Cheng, and Wang, Xiaoyong
- Subjects
- *
RISK assessment , *RESEARCH funding , *T-test (Statistics) , *DIABETIC nephropathies , *LOGISTIC regression analysis , *DESCRIPTIVE statistics , *MULTIVARIATE analysis , *MANN Whitney U Test , *CHI-squared test , *RETROSPECTIVE studies , *ODDS ratio , *HELICOBACTER diseases , *TYPE 2 diabetes , *STATISTICS , *DATA analysis software , *CONFIDENCE intervals , *DISEASE risk factors , *DISEASE complications - Abstract
Background: Previous studies examined the association of Helicobacter pylori infection (H. pylori) with complications of diabetes, but the results have been inconsistent. The aim of this study of patients with type-2 diabetes (T2D) was to determine the association of H. pylori infection with the major complications of diabetes. Methods: This single-center retrospective study examined patients with T2D who received H. pylori testing between January 2016 and December 2021. Logistic regression analyses were used to evaluate the association of H. pylori infection with four major complications of diabetes. Results: We examined 960 patients with T2D, and 481 of them (50.1%) were positive for H. pylori. H. pylori infection was significantly associated with diabetic nephropathy (odds ratio [OR] = 1.462; 95% confidence interval [CI]: 1.006,2.126; P = 0.046). In addition, the co-occurrence of H. pylori positivity with hypertension (OR = 4.451; 95% CI: 2.351,8.427; P < 0.001), with glycated hemoglobin A1c (HbA1c) of at least 8% (OR = 2.925; 95% CI: 1.544,5.541; P = 0.001), and with diabetes duration of at least 9 years (OR = 3.305; 95% CI:1.823,5.993; P < 0.001) further increased the risk of diabetic nephropathy. There was no evidence of an association of H. pylori infection with retinopathy, neuropathy, or peripheral vascular disease. Conclusions: Our study of T2D patients indicated that those with H. pylori infections had an increased risk of nephropathy, and this risk was greater in patients who also had hypertension, an HbA1c level of 8% or more, and diabetes duration of 9 years or more. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
15. Effect of a Triterpenoid-Rich Olive Oil on Chronic Kidney Disease in an Experimental Model of Diabetes Mellitus.
- Author
-
De La Cruz, José Pedro, Osuna-Esteban, Laura, Rodríguez-Pérez, María Dolores, Ortega-Hombrados, Laura, Sánchez-Tévar, Ana María, Martín-Aurioles, Esther, Fernández-Prior, María África, Pérez-Burillo, Sergio, Espejo-Calvo, Juan Antonio, and González-Correa, José Antonio
- Abstract
The aim of this study was to assess the effect of triterpenoids on the development of diabetic nephropathy in an experimental model of diabetes mellitus. For this purpose, a destoned and dehydrated olive oil (DDOO) was used, comparing its effects to a destoned olive oil (DOO). DDOO had a higher triterpenoid content than DOO but an equal content of alcoholic polyphenols. Four study groups (n = 10 animals/group) were formed: healthy rats, diabetic control rats (DRs), and DRs treated orally with 0.5 mL/kg/day of DOO or DDOO for two months. DRs showed impaired renal function (proteinuria, increased serum creatinine, decreased renal creatinine clearance) and morphology (glomerular volume and glomerulosclerosis). These alterations correlated with increased systemic and renal tissue oxidative stress and decreased prostacyclin production. DDOO administration significantly reduced all variables of renal damage, as well as systemic and renal oxidative stress, to a greater extent than the effect produced by DOO. In conclusion, triterpenoid-rich olive oil may prevent kidney damage in experimental diabetes mellitus. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. The effect of Polygonum hyrcanicum Rech. f. hydroalcoholic extract on oxidative stress and nephropathy in alloxan-induced diabetic mice.
- Author
-
Arabnozari, Hesamoddin, Shaki, Fatemeh, Najjari, Abolfazl, Sharifianjazi, Fariborz, Sarker, Satyajit D., Habibi, Emran, and Nahar, Lutfun
- Subjects
- *
DIABETIC nephropathies , *ALLOXAN diabetes , *GALLIC acid , *INTRAPERITONEAL injections , *OXIDATIVE stress - Abstract
Diabetic nephropathy, characterized by inflammation and oxidative stress, poses a management challenge. This study investigates the effect of Polygonum hyrcanicum extract on diabetic nephropathy in alloxan-induced diabetic mice. In this experimental animal study, the P. hyrcanicum extract was prepared using continuous macerations. Thirty male Albino mice, divided into five groups, were induced with alloxan-induced diabetes. They received intraperitoneal injections of the plant extract (100 and 200 mg/kg) and metformin (300 mg/kg) for four weeks. Kidney and blood samples were collected to assess protein carbonyl, glutathione, lipid peroxidation, TNF-α and IL-6 levels. The amount of total flavonoid and phenolic content in the hydroalcoholic extract of P. hyrcanicum were 7.5 ± 0.3 mg of quercetin and 88.2 ± 1.3 mg gallic acid per gram of extract respectively. The antioxidant activity level of the hydroalcoholic extract was determined to be 1.78 ± 0.51 mM equivalent per gram of extract. Alloxan administration resulted in a significant reduction in glutathione levels and a significant increase in protein carbonyl, lipid peroxidation, TNF-α, and IL-6 levels. Hydroalcoholic extract of P. hyrcanicum effectively reduced oxidative stress markers and inflammatory cytokines (TNF-α, IL-6), indicating its potential in mitigating diabetic nephropathy. However, no significant difference in efficacy was observed between the 100 mg/kg and 200 mg/kg doses in terms of reducing these toxicities. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. Study the Correlation Between the Indian Diabetes Risk Score (IDRS) Value and Microvascular Complications in Newly Diagnosed Type 2 Diabetes Mellitus.
- Author
-
Agarwal, Pradeep, Suthar, Akashkumar, Rijhwani, Puneet, Suthar, Gautambhai, Gupta, Deepak, Jat, Ram K, Choudhary, Shrikant, Kumar, Vinit, Bhargava, Varun, and Jain, Jainendra
- Abstract
Background The initiation of type-2 diabetes mellitus (T2DM) is frequently asymptomatic and gradual. One reason newly diagnosed type-2 diabetes mellitus patients have a higher risk of microvascular problems is untreated long-standing hyperglycemia. The objective of our study was to evaluate the frequency of microvascular problems in recently diagnosed patients with type 2 diabetes mellitus at a tertiary care hospital in India. Material and Methods: A cross-sectional study was undertaken in the medicine department of a tertiary care hospital. The study included a cohort of 100 patients who were recently diagnosed with type 2 diabetes mellitus. Microvascular complications were diagnosed after a thorough study of the patient's medical history, clinical assessment, and pertinent diagnostic tests. Results: Subjects who had an IDRS score of 60 or higher showed a higher occurrence of peripheral neuropathy (86.5% vs 13.5%, p=0.371), retinopathy (91.7% vs 8.3%, p=0.157), and nephropathy (77.8% vs 22.2%, p=0.410) compared to subjects with an IDRS score below 60. However, there was no statistically significant difference in the occurrence of microvascular problems between the two IDRS subgroups. Those diagnosed with nephropathy exhibit a statistically significant higher average IDRS score compared to those without nephropathy (65.00±17.32 vs 62.66±12.50, p-value = 0.037). However, no statistically significant difference was detected in the mean values of the IDRS scores of the other two microvascular complications. Conclusion: IDRS is a valuable tool for predicting newly diagnosed type 2 diabetes mellitus. However, further large, multi-centric studies will be required to detect its usefulness in microvascular complications. [ABSTRACT FROM AUTHOR]
- Published
- 2024
18. Assessment of prevalence of diabetic nephropathy in type 2 DM patients: A tertiary care centre.
- Author
-
Chawdhary, V. K.
- Abstract
Background: Diabetic nephropathy is the leading cause of end-stage renal disease (ESRD) worldwide, and it is estimated that ∼20% of type 2 diabetic patients reach ESRD during their lifetime. Diabetic nephropathy is the leading cause of chronic kidney disease in patients starting renal replacement therapy and is associated with increased cardiovascular mortality. Diabetic nephropathy has been classically defined by the presence of proteinuria >0.5 g/24 h. This stage has been referred to as overt nephropathy, clinical nephropathy, proteinuria, or macroalbuminuria. Aims and Objectives: To Assess the prevalence of diabetic nephropathy in type 2 DM patients. Materials and Methods: In this prospective study, 52 patients diagnosed diabetics were studied. Group A had 26 patients with at least one risk factor are hypertension, hypercholesterolemia and obesity. Group B had 26 patients without any of the risk factors. Patients who were selected for presence of Diabetic nephropathy with abnormal serum Creatinine, creatinine clearance and urinary albumin levels. Results and Observations: As many as 8 out of 52 patients were found to have Diabetic nephropathy. The number was significantly higher in group A compared to group B. Incidence of nephropathy was higher with higher number of associated risk factors. Urinary microalbuminuria was the commonest abnormality, Serum creatinine was found in only 25.84% of total positive cases. Conclusion: The large differences observed in the prevalence of nephropathy among different studies could be attributed to the differences in study design and methodologies adopted for defining the disease. Hypertension, obesity and hypercholesterolemia can contribute to development of nephropathy, and also, urinary microalbuminuria appears to be much more sensitive than serum creatinine. [ABSTRACT FROM AUTHOR]
- Published
- 2024
19. Toll-Like Receptors and Diabetic Nephropathy: A Review of Recent Advances.
- Author
-
Gholami Chahkand, Mohammad Sadra, Tavakoli, Yasaman, Aghakhani, Ava, Askarzadeh, Monireh, Azimi, Hosein, Ghalamkarpour, Nogol, Alizadeh, Alaleh, Archin, Iman, Kermani, Sajad, Ansari, Akram, Poudineh, Mohadeseh, Mali, Zahra, Foroughi, Elaheh, Erabi, Gisou, Mazhari, Seyed Amirhossein, Fallahi, Mohammad Sadegh, Deravi, Niloofar, and Dadkhah, Parisa Alsadat
- Subjects
- *
TYPE 1 diabetes , *TYPE 2 diabetes , *KIDNEY failure , *TOLL-like receptors , *CHRONIC kidney failure - Abstract
Diabetic nephropathy (DN) is one of the most common kidney diseases, but its exact pathophysiology remains unknown. Toll-like receptors (TLRs) are innate immune receptors that recognize pathogen- and danger-associated molecular patterns, which can result in an inflammatory response. TLR4, TLR2, TLR5, TLR7, TLR8, TLR9, and TLR11 are essential in the pathogenesis of DN, according to recent evidence collected from both in vivo and in vitro studies. Studies have shown that TLR2 and TLR4 expression is higher in patients with renal failure and nephrotic diabetes. They also play critical roles in podocyte injury and inflammation caused by high glucose. TLR2 and TLR4 may be helpful therapeutic targets to prevent or delay DN in patients with type 2 diabetes mellitus. Additionally, TLR7 may contribute to kidney damage in type 1 diabetes mellitus, whereas downregulation of TLR9 expression inhibits inflammation and apoptosis pathways associated with DN. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
20. Sweat gland morphology and physiology in diabetes, neuropathy, and nephropathy: a review.
- Author
-
Singaram, Sudha, Ramakrishnan, Kalpana, Selvam, Jayashree, Senthil, Mallika, and Narayanamurthy, Vigneswaran
- Subjects
- *
SWEAT glands , *KIDNEY failure , *WEARABLE technology , *DIGITAL divide , *RESEARCH personnel - Abstract
Context: Sweat glands (SGs) play a vital role in thermal regulation. The function and structure are altered during the different pathological conditions. Objective: These alterations are studied through three techniques: biopsy, sweat analytes and electrical activity of SG. Methods: The morphological study of SG through biopsy and various techniques involved in quantifying sweat analytes is focussed on here. Electrical activities of SG in diabetes, neuropathy and nephropathy cases are also discussed, highlighting their limitations and future scope. Results and Conclusion: The result of this review identified three areas of the knowledge gap. The first is wearable sensors to correlate pathological conditions. Secondly, there is no device to look for its structure and quantify its associated function. Finally, therapeutic applications of SG are explored, especially for renal failure. With these aspects, this paper provides information collection and correlates SG with pathologies related to diabetes. Hence this could help researchers develop suitable technologies for the gaps identified. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
21. Relationship between fibrosis-4 score and microvascular complications in patients with type 2 diabetes mellitus.
- Author
-
Erdogan, Beril Turan, Tam, Abbas Ali, Baser, Husniye, Cuhaci Seyrek, Fatma Neslihan, Polat, Sefika Burcak, Ersoy, Reyhan, Topaloglu, Oya, and Cakir, Bekir
- Abstract
Nonalcoholic fatty liver disease is the most prevalent chronic liver disease globally and is linked to augmented susceptibility to type 2 diabetes mellitus (DM), cardiovascular disease, and microvascular complications inherent to DM, such as nephropathy, neuropathy, and retinopathy. The fibrosis-4 (FIB-4) scoring system, a noninvasive tool, is useful for predicting the extent of liver fibrosis across diverse pathologies. This study aimed to assess the potential predictive role of FIB-4 scores in microvascular complications associated with diabetes. The medical records of patients with type 2 DM admitted to our endocrinology clinic between February 2019 and December 2020 were retrospectively evaluated. Parameters including demographic attributes, fasting blood glucose, glycated hemoglobin, aspartate aminotransferase, alanine aminotransferase, thrombocyte levels, and microvascular complications were recorded. The FIB-4 score was computed, and patients were categorized based on these scores (<1.3 and ≥ 1.3). The analysis included 312 patients with a median age of 60 (50–68 years); 39.7 % were men. The median duration of diabetes was 10 years (5–20 years), and the median FIB-4 score was 0.93 (0.63–1.34). Neuropathy, nephropathy, and retinopathy were observed in 50.6 %, 31.4 %, and 34 % of the patients, respectively. Although the FIB-4 score did not differ significantly between patients with and without neuropathy or retinopathy, patients with nephropathy exhibited higher FIB-4 scores. Notably, patients with FIB-4 scores ≥ 1.3 demonstrated a significantly higher prevalence of nephropathy. Logistic regression analysis demonstrated that higher FIB-4 scores were significantly associated with an increased risk of nephropathy. The FIB-4 score is a cost-effective and straightforward tool with potential applicability in predicting nephropathy in individuals with type 2 DM. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. Effect of exercise-based rehabilitation on functional capacity and renal function in type 2 diabetes mellitus with nephropathy: a randomized controlled trial.
- Author
-
Nataraj, Megha, Maiya, G. Arun, Nagaraju, Shankar Prasad, Shastry, B. A., Shivashankara, K. N., Shetty, Sahana, and Mayya, Shreemathi S.
- Abstract
Introduction: Diabetic nephropathy is a growing public health challenge with implications on health. Renal function decline impacts the functional ability and overall health and well-being of individuals with diabetic nephropathy due to development of several renal manifestations. The objective of the study was to determine the effect of an exercise-based rehabilitation program on functional capacity and renal function among individuals with type 2 diabetic nephropathy. Methods: A total of 283 individuals were screened and 60 eligible participants aged 45–70 years with diabetic nephropathy were randomly allocated (n = 30 each) to the intervention group (IG) and control group (CG), respectively. The study outcome measures comprised of functional capacity (6-min walk test) and renal function assessed at baseline, 12th week and 24th week. Participants allocated to IG received 12 weeks of exercise based rehabilitation (comprising of supervised + home-based exercises) along with standard care and followed-up till 24th week. Results: The repeated measures ANOVA with Greenhouse–Geisser correction indicated significant timepoint*group interaction effect for 6-min walk distance F
(1.71, 90.59) = 619, p < 0.001, serum creatinine F(1.23, 65.14) = 174.8, p < 0.001, estimated glomerular filtration rate F(1.15, 60.88) = 105.2, p < 0.001, serum urea F(1.48, 78.45) = 261.4, p < 0.001 and urine protein F(1.13, 59.82) = 4.58, p < 0.328. Conclusion: The study found that exercise based rehabilitation improved both functional capacity and renal function among individuals with type 2 diabetic nephropathy. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
23. Preliminary assessment of heavy metals intake via food in CKDu affected Uddanam region of Srikakulam, Andhra Pradesh, India.
- Author
-
Gupta, Vidhu, Lal, Kanhaiya, and Sehgal, Meena
- Subjects
COPPER ,MUNG bean ,URANIUM ,CHROMIUM ,CHRONIC kidney failure ,HEAVY metals ,EDIBLE greens - Abstract
The present study aimed to assess metal/heavy metal intake by the population via food environment of the Uddanam region, a hotspot for chronic kidney disease of uncertain aetiology (CKDu) in India. The food samples included rice/paddy, marine/freshwater fish, green gram/black gram (whole), and green leafy vegetables (GLVs, i.e. amaranth/spinach). These were analysed for metal/heavy metal (chromium, nickel, copper, arsenic, lead, magnesium, calcium, aluminium, manganese, iron, zinc, barium, cadmium, mercury, and uranium) content using standard procedures. The total heavy metal intake was calculated as a sum of the intake from each food source. The daily dietary intake was compared to safe intake levels (from the Institute of Medicine of the National Academies and National Institute of Nutrition). The intake was higher than safe levels for lead, chromium, and manganese. It is advisable to reduce heavy metal exposure by adopting agricultural practices and public health interventions in terms of diet. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
24. Unveiling the Mysteries of Contrast-Induced Acute Kidney Injury: New Horizons in Pathogenesis and Prevention.
- Author
-
Wang, Zhong, Wang, Qiuhan, and Gong, Xuezhong
- Subjects
ACUTE kidney failure ,CONTRAST media ,LOW-calorie diet ,MESENCHYMAL stem cells ,STEM cell treatment - Abstract
The utilization of contrast media (CM) in clinical diagnostic imaging and interventional procedures has escalated, leading to a gradual increase in the incidence of contrast-induced acute kidney injury (CI-AKI). Presently, the scarcity of effective pharmacological treatments for CI-AKI poses significant challenges to clinical management. Firstly, we explore the pathogenesis of CI-AKI in this review. Beyond renal medullary ischemia and hypoxia, oxidative stress, cellular apoptosis, and inflammation, emerging mechanisms such as ferroptosis, release of neutrophil extracellular traps (NETs), and nitrosative stress, which offer promising avenues for the management of CI-AKI, are identified. Secondly, a comprehensive strategy for the early prevention of CI-AKI is introduced. Investigating the risk factors associated with CI-AKI is essential for the timely identification of high-risk groups. Additionally, exploring early sensitive biomarkers is crucial for early diagnosis. A synergistic approach that combines these sensitive biomarkers, CI-AKI risk factors, and disease risk prediction models enhances both the accuracy and efficiency of early diagnostic processes. Finally, we explore recent pharmacological and non-pharmacological interventions for the management of Cl-AKI. Beyond the traditional focus on the antioxidant N-acetylcysteine (NAC), we look at active compounds from traditional Chinese medicine, including tetramethylpyrazine (TMP), salvianolic acid B (Sal B), as well as emerging preventive medications like N-acetylcysteine amide (NACA), alprostadil, and others, which all showed potential benefits in animal and clinical studies for CI-AKI prevention. Furthermore, innovative strategies such as calorie restriction (CR), enhanced external counterpulsation (EECP), and mesenchymal stem cell therapy are highlighted as providing fresh insights into Cl-AKI prevention and management. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
25. Dynamics of Leukocyte Telomere Length in Patients with Fabry Disease.
- Author
-
Levstek, Tina, Breznik, Nika, Vujkovac, Bojan, Nowak, Albina, and Trebušak Podkrajšek, Katarina
- Subjects
ANGIOKERATOMA corporis diffusum ,HYPERTROPHIC cardiomyopathy ,STROKE ,DISEASE progression ,INVERSE relationships (Mathematics) - Abstract
Fabry disease (FD) leads to significant morbidity and mortality, which may indicate accelerated ageing. However, it is still unclear whether there is a relationship between telomere length (TL), a marker of biological ageing, and disease outcome. We aimed to examine the relationship between leukocyte TL (LTL) dynamics and the presence of advanced disease stages and/or late complications of FD, including hypertrophic cardiomyopathy, nephropathy and stroke, both cross-sectionally and longitudinally. DNA was extracted from peripheral blood leukocytes and quantitative PCR was utilized to determine relative LTL in 99 Fabry patients. In the longitudinal analysis, we included 50 patients in whom at least three measurements were performed over a period of 5–10 years. The results showed a significant inverse correlation between LTL and age (ρ = −0.20, p = 0.05). No significant differences in LTL were found between females and males (p = 0.79) or between patients receiving disease-specific therapy and those without (p = 0.34). In a cross-sectional analysis, no association was found between the presence (p = 0.15) or number (p = 0.28) of advanced stages of the disease and/or late complications and LTL. Similarly, in a longitudinal analysis, no difference in LTL dynamics was found regarding the presence (p = 0.16) of advanced stage organ involvement and/or late complications or their number. These findings indicate that LTL dynamics in adulthood may not be a reliable indicator of disease outcomes in Fabry patients. Therefore, LTL may more accurately reflect the disease burden in early life, when TL is primarily determined. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
26. A case report of multicentric carpotarsal osteolysis syndrome: Depiction of a debilitating disease course.
- Author
-
Li, Jennifer Yee‐ming, Ho, Fanny Tsz‐wai, Lee, Mianne, Chan, Joyce, Chung, Brian Hon‐yin, Tung, Joanna Yuet‐ling, and Ma, Alison Lap‐tak
- Abstract
Multicentric carpotarsal osteolysis syndrome (MCTO) is a rare skeletal disorder characterized by progressive osteolysis involving the carpal and tarsal bones, and often associated with nephropathy. It is caused by heterozygous mutation in the MAF bZIP transcription factor B (MAFB) gene. Heterogeneous clinical manifestation and wide spectrum of disease severity have been observed in patients with MCTO. Here, we report a case of a male patient who presented with kidney failure in childhood with progressive disabling skeletal deformity. He was diagnosed with MCTO at 31‐years‐old, where a de novo pathogenic heterozygous variant in NM_005461.5:c.212C>A: p.(Pro71His) of the MAFB gene was identified. While there has been little data on the long‐term prognosis and life expectancy of this disease, this case report sheds light on the debilitating disease course with multiple significant morbidities of a patient with MCTO throughout his lifetime of 33 years. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
27. Clinical practice guideline for the management of lipids in adults with diabetic kidney disease: abbreviated summary of the Joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) Guideline 2024.
- Author
-
Zac-Varghese, Sagen, Mark, Patrick, Bain, Steve, Banerjee, Debasish, Chowdhury, Tahseen A., Dasgupta, Indranil, De, Parijat, Fogarty, Damian, Frankel, Andrew, Goldet, Gabrielle, Karalliedde, Janaka, Mallik, Ritwika, Montero, Rosa, Sharif, Adnan, Wahba, Mona, Dhatariya, Ketan, McCafferty, Kieran, Lioudaki, Eirini, and Winocour, Peter
- Subjects
DIABETIC nephropathies ,DYSLIPIDEMIA ,TYPE 2 diabetes ,TYPE 1 diabetes ,HEALTH care teams ,CHRONIC kidney failure ,LIPIDS - Abstract
The contribution of chronic kidney disease (CKD) towards the risk of developing cardiovascular disease (CVD) is magnified with co-existing type 1 or type 2 diabetes. Lipids are a modifiable risk factor and good lipid management offers improved outcomes for people with diabetic kidney disease (DKD). The primary purpose of this guideline, written by the Association of British Clinical Diabetologists (ABCD) and UK Kidney Association (UKKA) working group, is to provide practical recommendations on lipid management for members of the multidisciplinary team involved in the care of adults with DKD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
28. Renal candidiasis associated with papillary necrosis in a captive tiger (Panthera tigris).
- Author
-
Wilson, Floyd D., Baughman, Brittany, Mauel, Michael J., Holifield, Michael, Todd, Donna, and Pace, Lanny
- Subjects
- *
TIGERS , *CANDIDIASIS , *CANDIDA , *BLOOD urea nitrogen , *URINARY organs , *CANDIDA albicans - Abstract
A 14‐year‐old male tiger developed anorexia with elevated blood urea nitrogen and creatinine levels. The patient had a palpable abdominal mass and demonstrated neutrophilic leukocytosis and anaemia. Leukocytes, yeast and bacteria were present in the urine. The animal was non‐responsive to therapy and was subsequently euthanised. Extensive acute renal papillary necrosis (RPN) with pyelonephritis, chronic nephritis and polycystic renal disease were evident during gross and microscopic pathology examinations. The histologic occurrence of fungal spores and pseudohyphae morphologically consistent with Candida species were observed within the necrotic papillary regions of the kidney and within multiple foci of mild parakeratotic hyperkeratosis present in the gingiva and tongue. Candida albicans along with a slight growth of Escherichia coli were recovered from kidney cultures. Possible contributory factors for the renal candidiasis and associated RPN include predisposing oral candidiasis, polycystic renal disease, ischaemic nephrosclerosis, age‐associated or other forms of immunodeficiency and therapy with meloxicam, a non‐steroidal anti‐inflammatory drug. The absence of apparent lower urinary tract involvement coupled with the presence of intravascular renal 'Candida emboli' suggest that chronic oral candidiasis was the probable source of the kidney infection. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
29. La orina más allá de los electrolitos: diagnóstico a través de las vesículas extracelulares.
- Author
-
Anfaiha-Sanchez, Miriam, Lago-Baameiro, Nerea, Santiago-Hernandez, Aranzazu, Martin-Blazquez, Ariadna, Pardo, María, Martin-Lorenzo, Marta, and Alvarez-Llamas, Gloria
- Abstract
Copyright of Nefrologia is the property of Revista Nefrologia and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2024
- Full Text
- View/download PDF
30. Clinical and instrumental features of cardiorenal syndrome in cats with hypertrophic cardiomyopathy
- Author
-
Varvara M. Byakhova, Olesya A. Petrukhina, Elena A. Notina, and Irina A. Bykova
- Subjects
cardiology ,echocardiography ,electrocardiography ,diagnostics ,heart failure ,nephropathy ,cardiorenal continuum ,Agriculture - Abstract
This research presents novel insights into the temporal dynamics of clinical and instrumental parameters pertaining to the emergence of cardiorenal syndrome in feline patients afflicted with hypertrophic cardiomyopathy. It elucidates that within pedigreed felines, the progression of congestive heart failure syndrome may precipitate the subsequent evolution and exacerbation of secondary renal damage, thus significantly complicating the trajectory of the primary pathological process. This study establishes, for the first time, theprevalence of cardiorenal syndrome, affecting 51.0% of the population within the broader cohort of cats afflicted with hypertrophic cardiomyopathy (n= 49). Moreover, it substantiates the role of the cardiorenal continuum in felines as apredictor of amore severe course of hypertrophic cardiomyopathy. Manifesting as concentric myocardial hypertrophy in domestic felines, cardiorenal syndrome is characterized by dyspnea, hypothermia, and circulatory insufficiency. Statistically significant findings include an elevated median nocturnal respiratory rate of 34.0 breaths/min (p0.001) compared to clinically healthy counterparts (18.0 breaths/min) in affected felines. Additionally, felines afflicted with hypertrophic cardiomyopathy and cardiorenal syndrome exhibit astatistically significant (p 0.001) elevation in median mean arterial blood pressure to 140.0 mmHg compared to clinically healthy counterparts (104.0 mmHg), sinus tachycardia at 199.0 beats/min (171.5 beats/min in healthy felines), resulting in astatistically significant (p 0.001) reduction in PQ intervals by 67.0 ms (75.5 ms in healthy felines), and an increase in QT interval by 204.0 ms (165.5 ms in healthy felines). Electrocardiographic assessments reveal indications of compromised intra-atrial and intraventricular conduction in hypertrophic cardiomyopathy-afflicted felines with cardiorenal syndrome, along with an augmented amplitude of the ventricular complex. Echocardiographic evaluations confirm alterations such as pulmonary vein dilation, pronounced left atrial anteroposterior enlargement, interventricular septal and left ventricular free wall hypertrophy, decreased longitudinal contractility of the left and right ventricles, and clinically significant diastolic dysfunction.
- Published
- 2024
- Full Text
- View/download PDF
31. Association of Helicobacter pylori infection with complications of diabetes: a single-center retrospective study
- Author
-
Zhuoya Li, Jie Zhang, Yizhou Jiang, Kai Ma, Cheng Cui, and Xiaoyong Wang
- Subjects
Helicobacter pylori ,Type-2 diabetes ,Complication ,Nephropathy ,Diseases of the endocrine glands. Clinical endocrinology ,RC648-665 - Abstract
Abstract Background Previous studies examined the association of Helicobacter pylori infection (H. pylori) with complications of diabetes, but the results have been inconsistent. The aim of this study of patients with type-2 diabetes (T2D) was to determine the association of H. pylori infection with the major complications of diabetes. Methods This single-center retrospective study examined patients with T2D who received H. pylori testing between January 2016 and December 2021. Logistic regression analyses were used to evaluate the association of H. pylori infection with four major complications of diabetes. Results We examined 960 patients with T2D, and 481 of them (50.1%) were positive for H. pylori. H. pylori infection was significantly associated with diabetic nephropathy (odds ratio [OR] = 1.462; 95% confidence interval [CI]: 1.006,2.126; P = 0.046). In addition, the co-occurrence of H. pylori positivity with hypertension (OR = 4.451; 95% CI: 2.351,8.427; P
- Published
- 2024
- Full Text
- View/download PDF
32. The effect of Polygonum hyrcanicum Rech. f. hydroalcoholic extract on oxidative stress and nephropathy in alloxan-induced diabetic mice
- Author
-
Hesamoddin Arabnozari, Fatemeh Shaki, Abolfazl Najjari, Fariborz Sharifianjazi, Satyajit D. Sarker, Emran Habibi, and Lutfun Nahar
- Subjects
Alloxan ,Diabetes ,Nephropathy ,Oxidative stress ,Polygonum hyrcanicum ,Medicine ,Science - Abstract
Abstract Diabetic nephropathy, characterized by inflammation and oxidative stress, poses a management challenge. This study investigates the effect of Polygonum hyrcanicum extract on diabetic nephropathy in alloxan-induced diabetic mice. In this experimental animal study, the P. hyrcanicum extract was prepared using continuous macerations. Thirty male Albino mice, divided into five groups, were induced with alloxan-induced diabetes. They received intraperitoneal injections of the plant extract (100 and 200 mg/kg) and metformin (300 mg/kg) for four weeks. Kidney and blood samples were collected to assess protein carbonyl, glutathione, lipid peroxidation, TNF-α and IL-6 levels. The amount of total flavonoid and phenolic content in the hydroalcoholic extract of P. hyrcanicum were 7.5 ± 0.3 mg of quercetin and 88.2 ± 1.3 mg gallic acid per gram of extract respectively. The antioxidant activity level of the hydroalcoholic extract was determined to be 1.78 ± 0.51 mM equivalent per gram of extract. Alloxan administration resulted in a significant reduction in glutathione levels and a significant increase in protein carbonyl, lipid peroxidation, TNF-α, and IL-6 levels. Hydroalcoholic extract of P. hyrcanicum effectively reduced oxidative stress markers and inflammatory cytokines (TNF-α, IL-6), indicating its potential in mitigating diabetic nephropathy. However, no significant difference in efficacy was observed between the 100 mg/kg and 200 mg/kg doses in terms of reducing these toxicities.
- Published
- 2024
- Full Text
- View/download PDF
33. La orina más allá de los electrolitos: diagnóstico a través de las vesículas extracelulares
- Author
-
Miriam Anfaiha-Sanchez, Nerea Lago-Baameiro, Aranzazu Santiago-Hernandez, Ariadna Martin-Blazquez, María Pardo, Marta Martin-Lorenzo, and Gloria Alvarez-Llamas
- Subjects
Chronic kidney disease ,ExoView® ,Leprechaun ,Nephropathy ,Urine ,Extracellular vesicles ,Diseases of the genitourinary system. Urology ,RC870-923 - Abstract
Resumen: Antecedentes y objetivo: Las vesículas extracelulares (VEs) reflejan el estado fisiopatológico de sus células de origen y constituyen un reservorio de información renal accesible en la orina. Cuando la biopsia no es una opción, las VEs se presentan como un centinela de funcionalidad y daño, constituyendo una aproximación no invasiva. Sin embargo, el análisis de las VEs de la orina requiere de un aislamiento previo que ralentiza y dificulta su traslación a la práctica clínica. El objetivo de este trabajo es mostrar la aplicabilidad de la tecnología «sensor de imágenes de reflectancia interferométrica de una sola partícula» (SP-IRIS) mediante la plataforma ExoView® para el análisis directo de las VEs de la orina y de proteínas implicadas en funcionalidad renal. Materiales y métodos: La tecnología ExoView® permite la cuantificación y el fenotipado de las VEs presentes en la orina y la cuantificación de sus proteínas, de membrana e internas. En este trabajo se aplica esta tecnología a la cuantificación de las VEs de la orina y de sus proteínas con expresión renal tubular, amnionless (AMN) y secreted frizzled-related protein 1 (SFRP1), empleando únicamente 5 μl de orina. La expresión tubular se confirmó por inmunohistoquímica. Resultados: El tamaño medio de las VEs analizadas fue de 59 ± 16 nm para las capturadas por la tetraspanina CD63, 61 ± 16 nm para las capturadas por la tetraspanina CD81 y 59 ± 10 nm para la tetraspanina CD9, siendo CD63 la subpoblación de VEs mayoritaria en la orina (48,92%). La distribución de AMN y SFRP1 en las 3 tetraspaninas de captura resultó ser similar para ambas proteínas, expresándose mayoritariamente en CD63 (48,23% para AMN y 52,1% para SFRP1). Conclusiones: Este trabajo evidencia la aplicabilidad y las ventajas de la técnica ExoView® para el análisis directo de las VEs de la orina, y su cargo proteico en relación con el túbulo renal. El empleo de volúmenes mínimos, 5 μl, y el tiempo total de análisis no superior a 3 h facilita la traslación a la práctica clínica diaria de las VEs como fuente de información diagnóstica. Abstract: Background and objective: Extracellular vesicles (EVs) reflect the pathophysiological state of their cells of origin and are a reservoir of renal information accessible in urine. When biopsy is not an option, EVs present themselves as sentinels of function and damage, providing a non-invasive approach. However, the analysis of EVs in urine requires prior isolation, which slows down and hinders translation to clinical practice. The aim of this study is to show the applicability of the “single particle interferometric reflectance imaging sensor” (SP-IRIS) technology through the ExoView® platform for the direct analysis of urine EVs and proteins involved in renal function. Materials and methods: The ExoView® technology enables the quantification and phenotyping of EVs present in urine and the quantification of their membrane and internal proteins. We have applied this technology to the quantification of urinary EVs and their proteins with renal tubular expression, amnionless (AMN) and secreted frizzled-related protein 1 (SFRP1), using only 5 μl of urine. Tubular expression was confirmed by immunohistochemistry. Results: The mean size of the EVs analysed was 59 ± 16 nm for those captured by tetraspanin CD63, 61 ± 16 nm for those captured by tetraspanin CD81, and 59 ± 10 nm for tetraspanin CD9, with CD63 being the majority EVs subpopulation in urine (48.92%). The distribution of AMN and SFRP1 in the three capture tetraspanins turned out to be similar for both proteins, being expressed mainly in CD63 (48.23% for AMN and 52.1% for SFRP1). Conclusions: This work demonstrates the applicability and advantages of the ExoView® technique for the direct analysis of urine EVs and their protein content in relation to the renal tubule. The use of minimum volumes, 5 μl, and the total analysis time not exceeding three hours facilitate the translation of EVs to daily clinical practice as source of diagnostic information.
- Published
- 2024
- Full Text
- View/download PDF
34. Clinical practice guideline for the management of lipids in adults with diabetic kidney disease: abbreviated summary of the Joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) Guideline 2024
- Author
-
Sagen Zac-Varghese, Patrick Mark, Steve Bain, Debasish Banerjee, Tahseen A. Chowdhury, Indranil Dasgupta, Parijat De, Damian Fogarty, Andrew Frankel, Gabrielle Goldet, Janaka Karalliedde, Ritwika Mallik, Rosa Montero, Adnan Sharif, Mona Wahba, Ketan Dhatariya, Kieran McCafferty, Eirini Lioudaki, and Peter Winocour
- Subjects
Diabetic kidney disease ,Lipid management ,Diabetes ,Lipids ,Chronic kidney disease ,Nephropathy ,Diseases of the genitourinary system. Urology ,RC870-923 - Abstract
Abstract The contribution of chronic kidney disease (CKD) towards the risk of developing cardiovascular disease (CVD) is magnified with co-existing type 1 or type 2 diabetes. Lipids are a modifiable risk factor and good lipid management offers improved outcomes for people with diabetic kidney disease (DKD). The primary purpose of this guideline, written by the Association of British Clinical Diabetologists (ABCD) and UK Kidney Association (UKKA) working group, is to provide practical recommendations on lipid management for members of the multidisciplinary team involved in the care of adults with DKD.
- Published
- 2024
- Full Text
- View/download PDF
35. Nephropathy Associated with Bacterial Diseases in Broiler Chicken in Kashmir Valley
- Author
-
Rafiq, Mehvish, Goswami, Pankaj, Yaqub, Mehreen, Shafi, Majid, Kamil, Shayaib Ahmad, and Shah, Showkat Ahmad
- Published
- 2024
- Full Text
- View/download PDF
36. Who Punched Me in the Back? Becoming a CKD Researcher
- Author
-
Firmin, Selena, Stranieri, Andrew, editor, Meredith, Grant, editor, and Firmin, Selena, editor
- Published
- 2024
- Full Text
- View/download PDF
37. Effect of Huaier Granule on the Treatment of Idiopathic Membranous Nephropathy
- Author
-
LinkDoc Technology (Beijing) Co. Ltd., Huazhong University of Science and Technology, and Xiangmei Chen, Dr.
- Published
- 2023
38. Effects of Probiotics and Fibers on Albuminuria in Persons With Type 1 Diabetes (ProFOS)
- Author
-
DSM Nutritional Products, Inc.
- Published
- 2023
39. Effectiveness and Safety of Danshen Injection for Acute Kidney Injury in Primary Nephrotic Syndrome
- Author
-
Tianxin Chen, associate chief physician
- Published
- 2023
40. Hypophosphatemic osteomalacia due to cadmium toxicity in silverware industry: A curious case of aches and pains
- Author
-
Ayan Roy, Taurja Saha, Jayaprakash Sahoo, and Abanti Das
- Subjects
cadmium ,heavy metal ,hypophosphatemia ,nephropathy ,osteomalacia ,Medicine - Abstract
Hypophosphatemic osteomalacia in an adult often gives clinical diagnostic challenges. Usually, they are caused by either tumor-induced osteomalacia or due to genetically mediated hypophosphatemia, particularly X-linked hypophosphatemia. However, heavy metal toxicity, leading to global proximal renal tubular dysfunction, is a rare cause, and in particular, cadmium toxicity is rarely encountered in clinical practice. The presence of bony pain and neurological deficit, along with a classical exposure history, provides the diagnostic clue. In this background, here we present a middle-aged man who had severe bony pains all over his body and lower back stiffness for five years. He underwent an initial workup as a suspected spondyloarthropathy but was later on, found to have hypophosphatemic osteomalacia and severe proximal renal tubular dysfunction. Further, the workup revealed elevated FGF-23. His occupational history revealed prolonged exposure to cadmium fumes in the silverware industry. He improved moderately with treatment; however, significant renal damage is still present. This case highlights the importance of considering cadmium toxicity in proper clinical and occupational contexts in the evaluation of hypophosphatemic osteomalacia in an adult.
- Published
- 2024
- Full Text
- View/download PDF
41. Antidiabetic effects of the heat-killed Actinomycetales species in the liver and kidney of diabetic rats
- Author
-
Monireh Khordadmehr, Solin Ghaderi, Mehran Mesgari Abbasi, Farinaz Jigari-Asl, Katayoon Nofouzi, and Graham McIntyre
- Subjects
type 1 diabetes mellitus ,gordonia bronchialis ,tsukamurella inchonensis ,hepatopathy ,nephropathy ,Veterinary medicine ,SF600-1100 - Abstract
Type 1 diabetes mellitus (T1DM) occurs due to the decrease in insulin secretion following the destruction of pancreatic beta cells. This disease is increasing worldwide, especially among children under the age of 5 years, which is usually associated with irreversible complications such as hepatopathy and nephropathy. The present study aimed to investigate the antidiabetic effect of the heat-killed Actinomycetales species, including Gordonia bronchialis (Gb), and Tsukamurella inchonensis (Ti) in streptozotocin-diabetic rats by oral administration. This experiment was performed in six groups, including healthy control, diabetic control, low-dose Gb (G1), high-dose Gb (G2), low-dose-Ti (T1), and high-dose Ti (T2). Subsequently; the levels of ALT, AST, total protein, albumin, BUN, creatinine, CRP, IL-1β, and IL-2 were measured in the serum samples in the 14th and 21st days. Besides, histopathological lesions were studied in the liver and kidney. Our findings showed that Gb and Ti could alter the examined serum parameters, particularly in the T2 groups. Also, histological examination revealed a remarkable attenuation in the pathological lesions such as focal necrosis, vascular congestion, and hemorrhage in the liver and kidney of the treated rats by Gb and Ti. Here, it is concluded that oral administration of the heat-killed Actinomycetales species, particularly with a high dose of Ti, could beneficially improve the progression of T1DM and its various complications, which can be used to treat T1DM in the future.
- Published
- 2024
- Full Text
- View/download PDF
42. Potential role of resveratrol in prevention and therapy of diabetic complications: a critical review
- Author
-
Mehdi Koushki, Masoumeh Farahani, Reyhaneh Farrokhi Yekta, Naghmeh Frazizadeh, Parisa Bahari, Negin Parsamanesh, Hossein Chiti, Somayeh Chahkandi, Mohammadjavad Fridoni, and Nasrin Amiri-Dashatan
- Subjects
resveratrol ,diabetes mellitus ,nephropathy ,retinopathy ,neuropathy ,diabetic foot ulcer ,cardiomyopathy ,Nutrition. Foods and food supply ,TX341-641 - Abstract
Background: Diabetes mellitus (DM) is a category of metabolic conditions affecting about 5% of people worldwide. High mortality associated with DM is mostly due to its severe clinical complications, including diabetic nephropathy, retinopathy, neuropathy, and cardiomyopathy. Resveratrol (RSV) is a natural, biologically active polyphenol known to have various health-promoting effects in animal models and humans. Objective: In this review, we have reviewed the preventive and therapeutic role of RSV on diabetes complications with emphasis on its molecular mechanisms of action. Methods: To prepare this review, all the basic and clinical available literatures regarding this topic were gathered through electronic databases, including PubMed, Web of Science, Scopus, and Google Scholar. Therefore, we summarized previous studies that have evaluated the effects of RSV on diabetic complications and their mechanisms. Only English language studies published up to January 2023 were included in this review. Results: RSV improves glucose homeostasis, decreases insulin resistance, induces autophagy, regulates lipid metabolism, protects pancreatic β-cells, ameliorates metabolic disorders, and increases the GLUT4 expression. These effects induced by RSV are strongly associated with ability of this polyphenol agent to elevation expression/activity of AMP-activated protein kinase and Sirtuin 1 in various organs of diabetic subjects, which leads to prevention and therapy of diabetic complications. In addition, antioxidant and anti-inflammatory properties of RSV were reported to be involved in its action in diabetic complications, such as retinopathy and nephropathy. Conclusion: RSV is a promising compound for improving diabetic complications. However, the exact antidiabetic mechanisms of RSV need to be further investigated.
- Published
- 2024
- Full Text
- View/download PDF
43. Kidney and heart failure events are bidirectionally associated in patients with type 2 diabetes and cardiovascular disease
- Author
-
Abhinav Sharma, Silvio E. Inzucchi, Jeffrey M. Testani, Anne Pernille Ofstad, David Fitchett, Michaela Mattheus, Subodh Verma, Faiez Zannad, Christoph Wanner, and Bettina J. Kraus
- Subjects
Heart failure ,Kidney disease ,Nephropathy ,Type 2 diabetes ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Abstract Aims This study aimed to evaluate the bidirectional relationship between kidney and cardiovascular (CV) events in trial participants with type 2 diabetes and CV disease. Methods and results Post hoc analyses of EMPA‐REG OUTCOME using Cox regression models were performed to assess the association of baseline factors with risk of a kidney event and bidirectional associations of incident kidney events and CV events. Among placebo‐treated participants, baseline factors significantly associated with greater kidney event risk included lower baseline estimated glomerular filtration rate, albuminuria, higher uric acid, low‐density lipoprotein cholesterol levels, and prior heart failure (HF). Coronary artery disease was not associated with increased risk. In placebo‐treated participants, occurrence of an incident non‐fatal kidney event increased the subsequent risk of hospitalization for HF (HHF) but not 3‐point major adverse CV events (non‐fatal stroke, non‐fatal myocardial infarction, and CV death). Vice versa, HHF (but not myocardial infarction/stroke) increased the risk of subsequent kidney events. These associations were generally also seen in empagliflozin‐treated participants and in the overall population. Interestingly, the risk of kidney events following HHF was not significantly increased in the relatively small number of placebo‐treated participants already diagnosed with HF at baseline. Conclusions These findings demonstrate a bidirectional inter‐relationship between HHF and kidney events. Further exploration of this relationship and strategies to optimize the use of therapies to reduce both kidney and HF outcomes is warranted.
- Published
- 2024
- Full Text
- View/download PDF
44. Causal relationship between T2DM microvascular complications and gut microbiota: a Mendelian randomization study.
- Author
-
Junping Zhang, Zilu Yu, Shanshan Li, Qingfang Zhang, Wen Chen, Jingying Wang, Shasha He, Ying Liu, Shen Chen, and Jixiong Xu
- Subjects
GUT microbiome ,TYPE 2 diabetes ,GENOME-wide association studies ,SINGLE nucleotide polymorphisms ,CONSORTIA ,FREE flaps - Abstract
Background: Gowing number of studies have demonstrated the association between gut microbiome and T2DM microvascular complications, however the causal relationship remains unclear. Therefore, we using the Mendelian randomization (MR) approach to investigate this causal relation. Methods: Using gut microbiome data from the International MiBioGen Consortium genome-wide association study (GWAS) and T2DM microvascular complications data from the FinnGen Consortium GWAS to perform MR analyses. Single nucleotide polymorphisms (SNPs) were selected as instrumental variables (IVs), the inverse variance weighting (IVW) method was used as the primary analysis method, and the results were tested for heterogeneity and horizontal pleiotropy. Results: Our research identified that there are 5 known microbial species and 2 unknown microbial species in the gut microbiome that were causally related to T2DM retinopathy. Besides, three and seven known microbial species causal relationships between the gut microbiome and T2DM neuropathy and T2DM nephropathy, respectively. Conclusions: Using MR methods, we demonstrated the causal relationship between gut microbiome and microvascular complications in T2DM, providing a new strategy for the prevention and treatment of it. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
45. Unveiling the crucial role of intercellular adhesion molecule‐1 in secondary diabetic complications.
- Author
-
Kaur, Prabhnain, Dahiya, Ritu, Nandave, Mukesh, Sharma, Kalicharan, and Goyal, Ramesh K.
- Subjects
- *
CD54 antigen , *DIABETIC retinopathy , *DIABETES complications , *ENDOTHELIUM diseases , *DIABETES , *INFLAMMATION - Abstract
Diabetes mellitus is associated with secondary complications such as diabetic retinopathy (DR), nephropathy (DN), and cardiomyopathy (DCM), all of which significantly impact patient health. Intercellular adhesion molecule‐1 (ICAM‐1) has been implicated in inflammatory responses and endothelial dysfunction, both crucial in the pathogenesis of these complications. The goal of this review is to investigate at potential therapy methods that target ICAM‐1 pathways and to better understand the multifaceted role of ICAM‐1 in secondary diabetic problems. A meticulous analysis of scholarly literature published globally was conducted to examine ICAM‐1involvement in inflammatory processes, endothelial dysfunction, and oxidative stress related to diabetes and its complications. Elevated ICAM‐1 levels are strongly associated with augmented leukocyte adhesion, compromised microvascular function, and heightened oxidative stress in diabetes. These pathways contribute significantly to DR, DN, and DCM pathogenesis, highlighting ICAM‐1 as a key player in their progression. Understanding ICAM‐1 role in secondary diabetic complications offers insights into novel therapeutic strategies. Targeting ICAM‐1 pathways may mitigate inflammation, improve endothelial function, and ultimately attenuate diabetic complications, thereby enhancing patient health outcomes. Continued research in this area is crucial for developing effective targeted therapies. Significance statement: This review centers its attention on the function of intercellular adhesion molecule‐1 (ICAM‐1) in the development and progression of diabetic retinopathy, nephropathy, and cardiomyopathy.The role of ICAM‐1 in the pathophysiology of various disorders is investigated.The article emphasizes the significance of ICAM‐1 as a critical target for therapeutic interventions and the molecular mechanisms behind the contribution of ICAM‐1 are explored. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
46. Tip 2 Diyabet Hastalarında Spot İdrarda Albüminüri Sıklığı ve Etkileyen Faktörlerin Değerlendirilmesi.
- Author
-
Kocaman, Tayfun Barış, Yavuz, Erdinç, and Yurt, Nur Şimşek
- Abstract
Objective: This study aimed to determine the frequency of albuminuria in urine among Type 2 diabetic patients attending primary healthcare and to assess the factors influencing albuminuria. Methods: The research was conducted as a cross-sectional descriptive study between June 1, 2020, and August 31, 2020, at Kanyon Family Health Center in the Vezirköprü district of Samsun province. The study included 211 individuals. After obtaining informed consent from the participants, a face-to-face study form was administered to gather sociodemographic characteristics, smoking habits, comorbidities, and medication information. Albuminuria was detected using test strips, and the color change in the strip was evaluated by the same researcher in daylight each time, and the albumin/creatinine ratio in instantaneous spot urine was approximately calculated. Data analysis was performed with SPSS 24.0 (SPSS 24.0 for Windows, SPSS Inc., Chicago, IL, USA). Results: Of the participants, 52.1% (n=110) were female. The average age was 59.8±13.3 years (min:25-max:80). Hypertension was diagnosed in 47.4%, atherosclerotic heart disease in 27%, hyperlipidemia in 23.7%, obesity in 22.7%, and cerebrovascular disease in 2.4%. When the duration of diabetes diagnosis was evaluated, 27.5% had been diagnosed with diabetes for 0-5 years, 26.6% for 6-10 years, 15.6% for 11-15 years, 14.2% for 16-20 years, and 16.1% for more than 20 years. In addition, 39.3% had been regular smokers for the last 6 months and 37% had never smoked in their lives. 78.7% (n=166) of the patients were normoalbuminuric, 19% (n=40) were microalbuminuria, and 2.4% (n=5) were macroalbuminuria when albumin/creatinine ratio in spot urine was evaluated. The incidence of microalbuminuria and severe albuminuria was significantly higher in older patients, those with longer durations of diabetes, and former smokers (all; p<0.001). A positive correlation was found between age, duration of diabetes, hypertension, obesity, and albuminuria (r: 0.48, r: 0.68, r: 0.47, r: 0.55; p≤0.05, respectively). Microalbuminuria levels were higher in patients who had smoked throughout their lives compared to smokers and never smokers (p≤0.05). Furthermore, patients diagnosed with Type 2 diabetes for 16-20 years and over 20 years had higher microalbuminuria levels than those newly diagnosed (p<0.001). Conclusion: In our study, age, duration of diabetes diagnosis, hypertension, obesity, and smoking history were associated with albuminuria. By integrating practical screening protocols and adopting a holistic approach to patient care, family physicians can play an important role in reducing the burden of diabetic nephropathy in primary health care and improving patient outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
47. Hypophosphatemic osteomalacia due to cadmium toxicity in silverware industry: A curious case of aches and pains.
- Author
-
Roy, Ayan, Saha, Taurja, Sahoo, Jayaprakash, and Das, Abanti
- Subjects
- *
HEAVY metal toxicology , *HEAVY metals , *KIDNEY diseases , *HYPOPHOSPHATEMIA , *CADMIUM , *RENAL tubular transport disorders , *OSTEOMALACIA - Abstract
Hypophosphatemic osteomalacia in an adult often gives clinical diagnostic challenges. Usually, they are caused by either tumor‑induced osteomalacia or due to genetically mediated hypophosphatemia, particularly X‑linked hypophosphatemia. However, heavy metal toxicity, leading to global proximal renal tubular dysfunction, is a rare cause, and in particular, cadmium toxicity is rarely encountered in clinical practice. The presence of bony pain and neurological deficit, along with a classical exposure history, provides the diagnostic clue. In this background, here we present a middle‑aged man who had severe bony pains all over his body and lower back stiffness for five years. He underwent an initial workup as a suspected spondyloarthropathy but was later on, found to have hypophosphatemic osteomalacia and severe proximal renal tubular dysfunction. Further, the workup revealed elevated FGF‑23. His occupational history revealed prolonged exposure to cadmium fumes in the silverware industry. He improved moderately with treatment; however, significant renal damage is still present. This case highlights the importance of considering cadmium toxicity in proper clinical and occupational contexts in the evaluation of hypophosphatemic osteomalacia in an adult. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
48. Inborn errors of immunity with kidney and urinary tract disorders: a review.
- Author
-
Shajari, Ahmad, Zare Ahmadabadi, Atefe, Ashrafi, Mohammad Moein, Mahdavi, Tolue, Mirzaee, Mahbubeh, Mohkam, Masoumeh, Sharafian, Samin, Tamiji, Mehrdad, and Jamee, Mahnaz
- Abstract
Human inborn errors of immunity (IEIs), previously referred to as primary immunodeficiency disorders (PIDs), are a heterogeneous spectrum of inherited abnormalities of the immune system with different organ involvement. The number of identified IEIs is rapidly increasing, highlighting the non-negligible role of an interdisciplinary approach in clinical diagnosis. Kidney disorders are one of the important comorbidities in some of the affected patients and play a significant role in the diagnosis and course of disease. According to recent studies, 22 types of human IEI with renal manifestations have been identified so far, including immunodeficiency with congenital thrombocytopenia, thymic defects with additional congenital anomalies, complement deficiencies, type 1 interferonopathies, immunity related to non-hematopoietic tissues, congenital neutropenia's, common variable immunodeficiency disorder (CVID) phenotype and immuno-osseous dysplasia. Based on this classification, we herein review IEIs with renal features and explain the genetic defect, inheritance, and type of renal manifestations. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
49. Investigation of MHR-nephropathy relationship and the effect of SGLT2is on MHR in patients with type 2 diabetes.
- Author
-
Tekin, Bedriye Gizem and Pektaş, Erengül
- Abstract
Objective: The aim of this study was to evaluate the relationship between monocyte/high-density lipoprotein (HDL) ratio (MHR), an inflammatory marker, and diabetic nephropathy (DN), a microvascular complication of diabetes in diabetic patients and to investigate the effect of sodium-glucose co-transporter 2 inhibitors (SGLT2i) on MHR. Material and methods: The study included 119 diabetic patients. Hemogram, glucose, HbA1c, urea, creatinine, albumin, HDL cholesterol, LDL cholesterol, triglycerides, total cholesterol, MHR, NLR (neutrophil-lymphocyte ratio), and CRP parameters were evaluated in blood parameters taken after 8–10 h of fasting before and 6 months after SGLT2 inhibitor use, and albumin, creatinine, and albumin/creatinine parameters were evaluated in urine samples. Parameters were compared according to nephropathy status and SGLT2i type used. Results: The MHR in diabetic nephropathy (DN (+)) patients was significantly higher than in DN (−) patients (p = 0.005). There was no significant difference in NLR value in both groups. The MHR value decreased significantly after the use of SGLT2i in all patients participating in the study (p = 0.01). NLR value decreased in DN (−) patients after SGLT2i use. No difference was observed in DN (+) patients. Conclusion: In this study, results supporting the relationship between DN and MHR and the effect of SGLT2i drugs on MHR were found. The use of MHR value as a marker in clinical course monitoring and shaping the treatment according to these markers may be useful in terms of prediction and treatment of complications. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
50. Preventive and Therapeutic Efficacy of Roselle Beverage Residue in Late-Stage Type 2 Diabetic Rats.
- Author
-
Regalado-Rentería, Evelyn, Serna-Tenorio, Jesús E., García-Gutiérrez, David G., Reynoso-Camacho, Rosalía, García, Olga P., Anaya-Loyola, Miriam A., and Pérez-Ramírez, Iza F.
- Subjects
PEOPLE with diabetes ,TYPE 2 diabetes ,ROSELLE ,TREATMENT effectiveness ,RATS ,INSULIN sensitivity ,CINNAMON - Abstract
The residue from roselle beverage production is rich in polyphenols and dietary fiber. We investigated its potential as a preventive and therapeutic agent for type 2 diabetes mellitus (T2DM). Male Wistar rats were fed a high-fat high-fructose diet (HFFD) for 17 weeks, reaching insulin resistance by week 9, and induced to T2DM with streptozotocin (STZ) at week 13. Roselle beverage residue (RBR) was administered ad libitum mixed at 6% with the HFFD. Rats received HFFD+RBR as a preventive strategy starting at week 1 (healthy) and week 9 (insulin resistant), whereas the treatment strategy in T2DM rats started at week 14 alone or in combination with metformin (200 mg/kg/day), with a control metformin-treated group. All RBR-supplemented groups showed reduced serum glucose levels (1.4-fold to 1.8-fold) compared with the HFFD+STZ control group. Preventive RBR administration enhanced pancreatic function, leading to improved insulin sensitivity (6.5-fold to 7.9-fold). Gene expression analysis identified slight alterations in hepatic and skeletal muscle glucose metabolism. Additionally, RBR supplementation demonstrated a preventive role in mitigating hyperuricemia (2.1-fold to 2.2-fold), with no effect on glomerular hyperfiltration. While the exact mechanisms underlying RBR effects remain to be fully elucidated, our findings highlight its promising potential as a dietary supplement for preventing and treating T2DM. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.